Working together to enhance transitions of care for people with dementia - webinar

Using real-life case scenarios, the panel, consisting of a geriatrician, GP and nurse, will discuss the challenges of optimising transitions of care for people living with dementia.

This webinar has been developed in partnership with Dementia Training Australia.

Wednesday, 26 August 2020

7:00 – 8:00 pm AEST

View the learning outcomes.


Target audience: General practitioners, pharmacists and nurses

Open to: All health professionals and students

Cost: Free

CPD points: GPs, pharmacists and nurses - view details

About the webinar

This webinar focuses on the impact of transitions of care on changed behaviours among people with dementia. Panel members will provide practical advice on how to use the transition between hospital, home or an aged care facility as an opportunity to monitor and review management.

Meet the panel

Join our multidisciplinary panel as they provide their collective perspectives on working together as a team, and the importance of communicating with families and carers.

Kara Joyce (webinar facilitator)


Dr Brett Montgomery

Kara Joyce is the Clinical Lead on the NPS MedicineWise program, Dementia and changed behaviours: a patient-centred approach. Over the past 4 years Kara has been part of the national field force delivering NPS MedicineWise education programs to GPs and pharmacists. She is an accredited pharmacist who has a special interest in dementia care and will be the facilitator for this webinar.


Associate Professor Michael Woodward

Associate Professor Michael Woodward is Head of Aged Care Research at Austin Health in Melbourne. He is a specialist in geriatric medicine with major interests in the treatment of Alzheimer’s disease (AD) and other dementias, as well as quality use of medicines. As head of the Memory Clinic at this centre he is involved in several research trials of new therapies for AD and related disorders. He is a Past President of the AC4R – the Australasian Consortium of Centres for Clinical Cognitive Research –  that brings together researchers into therapeutic agents for dementia and is Honorary Medical Advisor for Dementia Australia.

In 2016 he was awarded Membership of the Order of Australia for his professional and academic work.


Dr Troye Wallett


Dr Troye Wallet is a GP with a specific interest in working with older Australians in aged care facilities. He feels privileged to have been on the Expert Advisory Committee for the RACGP Aged Care Guide (Silver Book) and sits on the Federal Aged Care Clinical Advisory Committee which is tasked with improving the use of antipsychotics in aged care facilities.

He is compelled to learn and teach and so he does. His style is open, engaging and conversational because no one likes boring lectures.


Dr Margaret Winbolt


Dr Margaret Winbolt is a Director with Dementia Training Australia (DTA) and Senior Research Fellow in the Australian Centre for Evidence Based Aged Care (ACEBAC) at La Trobe University. Margaret is a registered nurse with over 30 years’ experience and knowledge in the care of people with dementia and the needs of people with dementia and their carers. Margaret is the DTA Director responsible for the delivery of DTA’s Fellowship and GP education programs   

CPD points

RACGP

This activity has been approved for 2 points (CPD Activity) under the RACGP CPD Program for the 2020-2022 triennium (activity number: 208109).

ACRRM

This activity has been accredited for 1 hour under the educational activity category in the ACRRM PD Program for the 2020-2022 triennium (activity code: 20468).

APC

This activity is pending accreditation for 1 hour of Group 1 CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan.

ACN

This activity is pending endorsement for 1 CPD hour according to ACN Continuing Professional Development (CPD) Endorsed Course Standards.

Self-directed CPD

It is recommended that 1 CPD hour be recorded for the purposes of self-directed CPD.

Learning outcomes

By the end of this activity, participants should be able to:

  • Develop a management plan for each person, using a person-centred approach that involves the multidisciplinary team, to find non-pharmacological strategies to help manage behaviours
  • Identify that antipsychotics or benzodiazepines have only specific and short-term uses in the management of people with dementia who show changed behaviours
  • Review and monitor patients who are taking psychotropic medicines to assess the risk of harm from continued psychotropic use, as well as the potential benefits of deprescribing
Last modified: Friday, 24 July 2020, 8:28 AM